arbekacin has been researched along with panipenem in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aihara, Y; Fukamachi, K; Hori, T; Imamura, T; Kasuya, H; Kawashima, A; Kikuchi, K; Ochiai, T; Shiseki, M; Tozuka, K; Yamaguchi, K | 1 |
| Kimura, T; Kubo, H; Matsuura, N; Shimada, S; Sunakawa, K; Yago, K | 1 |
1 trial(s) available for arbekacin and panipenem
| Article | Year |
|---|---|
Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bayes Theorem; Body Weight; Creatinine; Dibekacin; Female; Gestational Age; Glomerular Filtration Rate; Humans; Infant, Newborn; Male; Models, Biological; Population; Thienamycins; Vancomycin | 2004 |
1 other study(ies) available for arbekacin and panipenem
| Article | Year |
|---|---|
[Two cases of methicillin-resistant Staphylococcus aureus (MRSA) sepsis following craniotomy].
Topics: Adult; Aged; Alanine; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Craniotomy; Dibekacin; Drug Therapy, Combination; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Methicillin Resistance; Postoperative Complications; Sepsis; Staphylococcal Infections; Sulbactam; Thienamycins; Treatment Outcome; Vancomycin | 2000 |